Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation.
Participants will:
undergo regular clinic follow-up visits in accordance with the guidelines undergo routine in-office follow-up and 5G cloud follow-up during each regular clinic visit
Age ≥ 18 years, gender unspecified;
Patients who have not undergone their first clinic follow-up after the implantation of cardiovascular implantable electronic devices (CIED); Note: In this study, CIED includes pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy pacemakers (CRT-P) and defibrillators (CRT-D), excluding implantable cardiac event recorders (ICM) and implantable cardiovascular monitors.
Willing to participate in this clinical study and have signed the informed consent form in writing.
Life expectancy < 1 year.
Inability to cooperate with treatment or follow-up, such as having mental illness.
Participated in other clinical studies within 30 days before enrollment. Other situations that the researcher deems unsuitable for inclusion.
The Third People's Hospital of Chengdu
Lead sponsor